X

Company Information

Company Name
X
Address
2810 N COMMERCE PKY
MIRAMAR, FL, -
Phone
n/a
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$2,101,511.00
9
SBIR Phase II
$6,284,086.00
4
Chart code to be here

Award List

  1. X

    Amount: $0.00

    X

    SBIR Phase II 2010 Department of Health and Human Services
  2. T-cell receptor based therapeutics for cytomegalovirus

    Amount: $100,000.00

    DESCRIPTION (provided by investigator): The goal of these studies is to evaluate the feasibility of using a T-cell receptor based fusion protein as a targeting agent for therapies for CMV, which remai ...

    SBIR Phase I 2003 Department of Health and Human Services
  3. NOVEL DRUG DISCOVERY FOR MULTIPLE SCLEROSIS

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term objective of this project is to develop small molecule inhibitors of TCR:MHC class II-peptide interactions for the treatment of multiple sclerosis (M ...

    SBIR Phase I 2003 Department of Health and Human Services
  4. Bifunctional T cell receptor based immunotherapeutics

    Amount: $1,112,023.00

    DESCRIPTION (provided by applicant): The goal of these studies is to further pre-clinical development of a soluble three-domain single chain T-cell receptor IL-2 fusion protein (264scTCR/IL-2). This T ...

    SBIR Phase I 2004 Department of Health and Human Services
  5. Bifunctional T cell receptor based immunotherapeutics

    Amount: $2,969,291.00

    DESCRIPTION (provided by applicant): The long-term objective of this project is to develop a tumor-targeted TCR-IL2 fusion protein, ALT-801, as an immunotherapeutic for treatment of p53-positive cance ...

    SBIR Phase II 2009 Department of Health and Human Services
  6. Soluble T-cell receptor based tumor screening reagents

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The goal of this research is to demonstrate proof-of-principle for using a T-cell receptor (TCR)-based fusion protein as a staining reagent for human tumors. The T ...

    SBIR Phase I 2004 Department of Health and Human Services
  7. Tissue Factor Antagonists for ALI/ARDS

    Amount: $110,542.00

    DESCRIPTION (provided by applicant): The objective of this project is to develop an anti-tissue factor antibody, Sunol-cH36, as a treatment for Acute Lung Injury (ALI) and Acute Respiratory Distress ...

    SBIR Phase I 2005 Department of Health and Human Services
  8. Transgenic Plant Technology for Producing Therapeutic Recombinant Antibodies

    Amount: $100,001.00

    DESCRIPTION (provided by applicant): The need to develop novel, cost effective manufacturing processes to produce therapeutic antibodies commercially will continue to be of considerable and growing i ...

    SBIR Phase I 2005 Department of Health and Human Services
  9. Transgenic Plant Technology for Producing Therapeutic Recombinant Antibodies

    Amount: $1,234,949.00

    DESCRIPTION (provided by applicant): There is an urgent need to develop novel, cost-effective manufacturing processes to produce therapeutic antibodies commercially in order to reduce the high manufac ...

    SBIR Phase II 2006 Department of Health and Human Services
  10. NOVEL DRUG DISCOVERY FOR RHEUMATOID ARTHRITIS

    Amount: $112,209.00

    DESCRIPTION (provided by applicant): The long-term objective of this project is to develop small molecule inhibitors of MHC class II activity for the treatment of rheumatoid arthritis (RA). The stron ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government